CLASS III Drug recall · Reported 1 Nov 2017 · FDA Enforcement Report

Fluocinonide Gel USP, 0.05% tube recalled by Taro Pharmaceuticals U.S.A

Taro Pharmaceuticals U is recalling Fluocinonide Gel USP, 0.05% tube, distributed nationwide in the US. The recall was initiated on 20 Sep 2017 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: A771026850, Exp 6/18
NDC51672-1254, 51672-1253, 51672-1279, 51672-1264
UPC0351672126414, 0351672127923
Quantity recalled16,944 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0146-2018
FDA event ID
78157
Recalling firm
Taro Pharmaceuticals U, Hawthorne, NY
Manufacturer
Sun Pharmaceutical Industries, Inc.
Classification
Class III
Status
Terminated
Recall initiated
20 Sep 2017
FDA classified
29 Dec 2017
Reported
1 Nov 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

20 Sep 2017Recall initiated by company
1 Nov 2017Published in enforcement report+42 days
29 Dec 2017Classified by FDA+58 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Cross contamination with other products: traces of Dapsone were found in the finished product.

Product as listed by the FDA

Fluocinonide Gel USP, 0.05%, 15 g tube, Rx Only, Mfd. by: Taro Pharmaceuticals Inc. Brampton Ontario Canada L6T1C1, Dist. by: Taro Pharmaceuticals U.S.A . Inc. Hawthorne NY 10532, NDC 51672-1279-1

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Why was it recalled?

Cross contamination with other products: traces of Dapsone were found in the finished product.

Which lots are affected?

Lot #: A771026850, Exp 6/18

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Taro Pharmaceuticals U

All 36

Other Fluocinonide recalls

All 11